Cellvax
Drug validation studies accelerates
- B2B
About Cellvax
A preclinical CRO specializing in innovative drug validation studies in Cancer and Osteoarthritis fields, accelerating drug development for severe human diseases
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Maisons-Alfort, Île-de-France, France
- Founded
- 2001
- Revenue
- $3.3M – $26.4MTamtam estimate
- Website
- cellvax-pharma.com
Cellvax at a glance
Cellvax is a B2B company in the Biotechnology Research industry, headquartered in Maisons-Alfort, Île-de-France, France.
Cellvax was founded in 2001.
Cellvax has 1–10 employees.
Cellvax's revenue is $3.3M – $26.4M (Tamtam estimate).
Selling to companies like Cellvax?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies